Drug Efficacy

Beta-Blockers Offer No Benefit After Heart Attack With Preserved Heart Function, Meta-Analysis Finds

NEJM data from 17,801 patients point toward guideline changes that reserve treatment for reduced ejection fraction or other clear indications.